STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Tarsus to Participate in Upcoming Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Tarsus Pharmaceuticals (NASDAQ: TARS) has announced its upcoming participation in the Barclays 27th Annual Global Healthcare Conference. The company's management will engage in a fireside chat scheduled for Tuesday, March 11th at 8:00 a.m. / 11:00 a.m. ET.

Interested parties can access a live webcast of the presentation through the events section of the Tarsus website. A replay of the session will be made available within 48 hours and will remain accessible for a time on the company's website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

IRVINE, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the Barclays 27th Annual Global Healthcare Conference on Tuesday, March 11th, at 8:00 a.m. / 11:00 a.m. ET.

A live webcast and additional information can be accessed on the events section of the Tarsus website. The replay will be available on the Tarsus website within 48 hours and will be archived for a limited time.

About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution, 0.25%) is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease.

Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com

Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com


FAQ

When is Tarsus Pharmaceuticals (TARS) presenting at the Barclays Healthcare Conference 2025?

Tarsus Pharmaceuticals will present on Tuesday, March 11th, 2025, at 8:00 a.m. PT / 11:00 a.m. ET.

How can investors watch Tarsus (TARS) presentation at the Barclays Conference?

Investors can watch the live webcast through the events section of the Tarsus website.

How long will the TARS Barclays Conference presentation replay be available?

The replay will be available on the Tarsus website within 48 hours and will be archived for a time.

What type of presentation will TARS deliver at the Barclays Healthcare Conference?

Tarsus management will participate in a fireside chat format presentation.
Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

TARS Rankings

TARS Latest News

TARS Latest SEC Filings

TARS Stock Data

3.42B
39.69M
3.18%
118.17%
16.41%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
IRVINE